Journal article
Monkeypox virus antibodies in healthy persons after vaccination with MVA-BN, United Kingdom
- Abstract:
-
A 2-dose regimen of the vaccine modified vaccinia Ankara–Bavarian Nordic (MVA-BN) can generate neutralizing antibodies for monkeypox virus clades Ib and IIb. We observed higher response to clade IIb; that result provides evidence that MVA-BN vaccination can induce cross-neutralizing antibodies for monkeypox virus clade Ib as well as for clade IIb.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 345.7KB, Terms of use)
-
- Publisher copy:
- 10.3201/eid3202.251553
Authors
- Publisher:
- Centers for Disease Control and Prevention
- Journal:
- Emerging Infectious Diseases More from this journal
- Volume:
- 32
- Issue:
- 2
- Pages:
- 302-305
- Publication date:
- 2026-02-15
- DOI:
- EISSN:
-
1080-6059
- ISSN:
-
1080-6040
- Pmid:
-
41714843
- Language:
-
English
- Pubs id:
-
2383175
- Local pid:
-
pubs:2383175
- Source identifiers:
-
W7129735293
- Deposit date:
-
2026-05-01
- ARK identifier:
Terms of use
- Copyright holder:
- Sheridan et al.
- Copyright date:
- 2026
- Rights statement:
- Copyright © 2026 The Author(s).
- Notes:
- The author accepted manuscript (AAM) of this paper has been made available under the University of Oxford's Open Access Publications Policy, and a CC BY public copyright licence has been applied.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record